SOURCE: Atlan International Holdings Corp.

May 31, 2007 06:25 ET

Atlan Introduces New Product Line

PRINCETON, NJ--(Marketwire - May 31, 2007) - Atlan International Holdings Corp. (FRANKFURT: QV8) (PINKSHEETS: ATLI), a company which is a global development, marketing, sales and acquisition firm with subsidiaries that develop, design and market pharmaceuticals, biotechnology, bio-pharmaceuticals, alternative medicines & nutraceuticals, and alternative energy & processes, announced today that its subsidiary Atlan Pharma Inc. prepared a line of nutraceutical and other food supplements, including vitamins and minerals, that will be entering the market in succession and in consideration of specific market needs.

The products given the priority are pediatric formulations of nutraceutical cough syrups and immune boosting products that are targeted for the coming 2007 flu season. Other pediatric products designed for pediatric patients are products for attention deficit hyperactivity disorders (ADHD) and nutraceutical products for treatment of common gastrointestinal functional disorders such as constipation. There will also be a line of pediatric vitamin and mineral preparations.

Adult nutraceutical preparations are targeted to aid control of common metabolic problems such as lipid disorders, diabetes, and obesity. Other adult products will address common health problems of the baby boom population and belong to classes of cardioprotectants, functional gastrointestinal disorders, nutraceutical cough syrups and immune-stimulants, and mood disorders.

Dr. Jerry Piotrowski, who heads the New Life's nutraceutical division, stated: "Our products take the advantage of the newest findings in the area of nutraceuticals and address the most common problems of the pediatric and adult populations. We will be one of the very few companies offering a full line of nutraceutical products, mainly syrups, in the coming flu season. Our products will fill the gap created by recent bans by the FDA of some of the most common pharmaceuticals that were used in formulations of cough and cold products."

Atlan plans to market the products in the US, Canada and throughout Europe.

About Atlan International Holdings Corp. (FRANKFURT: QV8) (PINKSHEETS: ATLI); Atlan is a global development, marketing, sales and acquisition firm with subsidiaries that develop, design and market pharmaceuticals, biotechnology, bio-pharmaceuticals, alternative medicines & nutraceutical, and alternative energy & processes. Atlan's international relationships and strengths allow it to offer products for co-development and to independently market & co-market multiple products.

Safe Harbor Statements under the Private Securities Litigation Reform Act of 1965: Those statements contained herein which are not historical are forward-looking statements, and as such, are subject to risks and uncertainties that could cause actual operating results to materially differ from those contained in the forward-looking statements. Such statements include, but are not limited to, certain delays that are beyond the company's control, with respect to market acceptance of new technologies, or product delays in the testing and evaluation of products, and other risks, as detailed in the company's periodic filings with the Securities and Exchange Commission.

Contact Information